Position in BLLN
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$108,152,369
+$8,688,523 QoQ
Shares Held
901,420
-28.5% QoQ
Ownership
1.91%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#3
of 156 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 89%
Shared 0%
None 11%
Common Shares in BLLN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026BAILLIE GIFFORD & CO holds $1,558,123,774 across 8 Diagnostics & Research names. BLLN ranks #7 (6.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GH |
Guardant Health, Inc.
|
2,284,127 | $342,687,571 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
645,648 | $323,702,080 | |
| 3 | MEDP |
Medpace Holdings, Inc.
|
473,211 | $250,607,812 | |
| 4 | ILMN |
Illumina, Inc.
|
1,335,846 | $234,881,800 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
353,797 | $186,252,891 | |
| 6 | TWST |
Twist Bioscience Corp
|
1,086,779 | $111,807,822 | |
| 7 | BLLN |
BillionToOne, Inc.
This page
|
901,420 | $108,152,369 | |
| 8 | DHR |
Danaher Corp /De/
|
165 | $31,429 |
All Filings in BLLN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $108,152,369 | 901,420 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $99,463,846 | 1,259,993 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $103,786,457 | 1,268,163 | Shares | Defined | 2026-01-23 | |
| No filing history on record for this holder in this stock. | ||||||